Exclusive Life Science Feature
Aptalis —
The "Three Ms"
Of Specialty Pharma
Mindset, mission, and model are the
self-defined keywords guiding a company
that applies its novel delivery technology
to new and existing drugs.
By Wayne Koberstein, executive editor
G
eneral surveys of specialty pharma (SP) are common in
the press, but deeper insights sometimes require looking
at a specific case. Aptalis Pharma US (Aptalis) serves as
both example and exception in shedding light on the SP sector.
The company's president and CEO, Frank Verwiel, M.D., coined
the "three Ms" — mindset, mission, and model — as organizing
keywords for the qualities and goals that distinguish SP from
other industry sectors and Aptalis from other SP companies.
The keywords triangulate and guide the company in its overall
strategic direction:
•
•
24
Mindset — applying the concept of innovation to improve drug delivery, bioavailability, safety, and
effectiveness of drugs for targeted populations
Mission — "To improve the health and quality of care by providing specialty therapies for
patients around the world." (Meaning: the mission is ambitious and global, but focused on a
well-defined sector.)
LifeScienceLeader.com
July 2013
